CSIMarket
 


Repligen Corp  (RGEN)
Other Ticker:  
 

Cumulative Repligen's Leverage Ratio for Trailing Twelve Months Period

RGEN's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

RGEN Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth 8.36 % 9.17 % 9.86 % 9.18 % 6.99 %
Y / Y Total Liabilities Growth -14.98 % -8.39 % -2.92 % 1.17 % 17.99 %
Leverage Ratio for Trailing Twelve Months Period 0.29 0.31 0.33 0.34 0.34
Total Ranking # 606 # 705 # 772 # 951 # 934
Seq. Equity Growth 0.89 % 1.57 % 1.56 % 4.12 % 1.65 %
Seq. Total Liabilities Growth -9.2 % -2.47 % -2.84 % -1.18 % -2.16 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to debt repayement of -9.2% Repligen decreased Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 0.29, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 49 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Repligen. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are RGEN's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 50
Sector # 278
S&P 500 # 531


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.7 0.3 0.12
(Mar 31 2017)   (June 30. 2014)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Xtant Medical Holdings Inc   0.79 
Freeline Therapeutics Holdings Plc  0.79 
Autolus Therapeutics Plc  0.76 
Titan Pharmaceuticals Inc   0.76 
Beam Therapeutics Inc   0.76 
Candel Therapeutics Inc   0.75 
Sangamo Therapeutics Inc   0.75 
Sana Biotechnology Inc   0.74 
Sab Biotherapeutics Inc   0.73 
Elevation Oncology inc   0.66 
Century Therapeutics inc   0.65 
Regenxbio Inc   0.64 
Lineage Cell Therapeutics Inc   0.62 
Kodiak Sciences Inc   0.62 
Finch Therapeutics Group Inc   0.55 
Qiagen N v   0.52 
Erytech Pharma S a   0.52 
C4 Therapeutics Inc   0.51 
Gritstone Bio Inc   0.50 
Vericel Corporation  0.49 
Ginkgo Bioworks Holdings Inc   0.47 
Recursion Pharmaceuticals Inc   0.47 
Aptose Biosciences Inc   0.46 
Bluebird Bio Inc   0.45 
Senti Biosciences Inc   0.44 
Aligos Therapeutics Inc   0.43 
Vaxart Inc   0.43 
Tcr2 Therapeutics Inc   0.42 
Genfit S a   0.42 
Inmune Bio Inc   0.41 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com